MALAISE is the #10 most commonly reported adverse reaction for TERIPARATIDE, manufactured by Eli Lilly and Company. There are 5,660 FDA adverse event reports linking TERIPARATIDE to MALAISE. This represents approximately 2.5% of all 227,333 adverse event reports for this drug.
TERIPARATIDE has an overall safety score of 78 out of 100. Patients taking TERIPARATIDE who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
MALAISE5,660 of 227,333 reports
MALAISE is a less commonly reported adverse event for TERIPARATIDE, but still significant enough to appear in the safety profile.
Other Side Effects of TERIPARATIDE
In addition to malaise, the following adverse reactions have been reported for TERIPARATIDE:
MALAISE has been reported as an adverse event in 5,660 FDA reports for TERIPARATIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is MALAISE with TERIPARATIDE?
MALAISE accounts for approximately 2.5% of all adverse event reports for TERIPARATIDE, making it a notable side effect.
What should I do if I experience MALAISE while taking TERIPARATIDE?
If you experience malaise while taking TERIPARATIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.